Nano Mobile Healthcare Inc (VNTH)

[DoingHomework]

It is the trends that are more troubling.

Every company does its best to put a positive light on developments, and this is completely expected. That is a different matter from what has been alleged to have happened in some other companies that were accused of issuing deliberately misleading releases. The commercialization path for VNTH lies through the FDA, and trials are a key part of that journey. At the present stage, one might ask, in light of the below releases, about the outcomes of the claimed trials.


From the November 20, 2014 press release:

"Vantage expects to further update its shareholders this winter on preliminary clinical trial results derived from using the new sensor for human breath."


From the July 2014 SEC filing:

"It is anticipated that preliminary human trials for the Vantage Health Sensor will begin next month at Scripps Translational Science Institute, paid for by a BioPharma partner of the Company."